In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Synthetic Genomics, United Therapeutics, Lung Biotech ally in organ transplants

Executive Summary

In a multi-year agreement, Synthetic Genomics Inc. (SGI; DNA-based products) is partnering with United Therapeutics Corp. and its Lung Biotechnology Inc. subsidiary to use synthetic genomics in the development of humanized pig organs for patients who will receive lung transplants.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Transgenics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • Includes Equity
    • R+D and Marketing-Licensing

Related Companies

UsernamePublicRestriction

Register